Kanamycin: Difference between revisions
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Kanamycin sulfate is an [[aminoglycoside]] [[antibiotic]], available in both oral and [[intravenous]] forms, and used to treat a wide variety of[[infection]]s. Kanamycin is isolated from ''Streptomyces kanamyceticus''. | |||
==Category== | ==Category== | ||
Aminoglycoside | |||
==US Brand Names== | ==US Brand Names== | ||
KANAMYCIN<sup>®</sup> (''DISCONTINUED''), KANAMYCIN SULFATE<sup>®</sup> (''DISCONTINUED''), KANTREX<sup>®</sup> (''DISCONTINUED''), KLEBCIL<sup>®</sup> (''DISCONTINUED'') | |||
==FDA Package Insert== | ==FDA Package Insert== | ||
Revision as of 15:33, 6 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Kanamycin sulfate is an aminoglycoside antibiotic, available in both oral and intravenous forms, and used to treat a wide variety ofinfections. Kanamycin is isolated from Streptomyces kanamyceticus.
Category
Aminoglycoside
US Brand Names
KANAMYCIN® (DISCONTINUED), KANAMYCIN SULFATE® (DISCONTINUED), KANTREX® (DISCONTINUED), KLEBCIL® (DISCONTINUED)
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages
Mechanism of Action
References
Pharmacology
Kanamycin works by affecting the 30S ribosomal subunit and causing a frameshift mutation or it prevents the translation of RNA. This means that instead of a codon CAT (for example in sequence CATG), a codon ATG is read by aminoacyl tRNA (aa-tRNA). Aminoacyl tRNA is consequently carrying a different amino acid, because the anticodon on the aa-tRNA is different. The protein needed cannot be synthesized: depending on the site and severity of the frame shift, either a completely different protein is synthesized, or a protein similar to the one needed is synthesized, but is folded incorrectly. A bacterium is destroyed because it cannot produce any of its proteins correctly.
Because of over-usage of antibiotics many bacteria have developed a resistance against kanamycin, and, consequently, it is not used much anymore.
Side effects
Common side effects include changes in hearing (either hearing loss or ringing in the ears), toxicity to kidneys, and allergic reactions to the drug.
Use in Research
Genes encoding kanamycin resistance are commonly used as selectable markers in molecular biology.
Template:Antidiarrheals, intestinal anti-inflammatory/anti-infective agents Template:AminoglycosideAntiBiotics